4.7 Review

The therapeutic voyage of pyrazole and its analogs: A review

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 120, 期 -, 页码 170-201

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2016.04.077

关键词

Heterocyclic; Pyrazole; Pharmacological activity; Anticancer; Antimicrobial; Antiviral; Analgesic; Anti-inflammatory

向作者/读者索取更多资源

Pyrazole, a five membered heteroaromatic ring with two nitrogen atoms is of immense significance. Presence of this nucleus in the pharmacological agents of diverse therapeutic categories viz. antianxiety, anti-inflammatory, antipsychotic, anticancer, antiobesity, analgesic, antipyretic etc. has made it an indispensable anchor for design and development of new pharmacological agents. Owing to the development of novel and new pyrazole based therapeutic agents at a faster pace, there is a need to couple the latest information with previously available information to understand status of this moiety in medicinal chemistry research. The review herein highlights the therapeutic worth of pyrazole derivatives. Several therapeutically active pyrazole based derivatives developed by numerous scientists across the globe are reported here. (C) 2016 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Instruments & Instrumentation

Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation

Tinku, Mohd. Mujeeb, Abdul Ahad, Mohd. Aqil, Waseem Ahmad Siddiqui, Abul Kalam Najmi, Mymoona Akhtar, Apeksha Shrivastava, Abdul Qadir, Thasleem Moolakkadath

Summary: This study successfully optimized rubiadin-loaded niosomes using Box-Behnken design for the management of diabetic nephropathy in Wistar rats. The optimized formulation showed significant anti-diabetic activity and improvement in biochemical parameters in Wistar rats. The findings suggest that the prepared RLN formulation has potential for the management of STZ-NA-induced DN.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Review Chemistry, Organic

Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets

Garvit Satija, Barkha Sharma, Anish Madan, Ashif Iqubal, Mohammad Shaquiquzzaman, Mymoona Akhter, Suhel Parvez, Mohammad Ahmed Khan, Mohammad Mumtaz Alam

Summary: Benzimidazole, a bicyclic aromatic compound, is an important pharmacophore for various bioactive heterocyclic compounds with numerous pharmacological activities. Recent research has focused on its potential as anticancer agents and the structure-activity relationships of compounds containing benzimidazole rings.

JOURNAL OF HETEROCYCLIC CHEMISTRY (2022)

Article Chemistry, Organic

Synthesis, and reverse screening of 6-(3,4,5-trimethoxyphenyl)pyrimidine-5-carbonitrile derivatives as anticancer agents: Part-II

Lalit Mohan Nainwal, Mohammad Shaququzzaman, Mymoona Akhter, Asif Husain, Suhel Parvez, Sharba Tasneem, Ashif Iqubal, Mohammad Mumtaz Alam

Summary: The sulfur-containing cyanopyrimidine derivative 4g showed promising broad-spectrum anticancer activity, with high growth inhibition against various cancer cell lines. These derivatives exhibited anticancer activity through different targets, indicating potential for further optimization to develop more effective multi-targeting anticancer agents.

JOURNAL OF HETEROCYCLIC CHEMISTRY (2022)

Review Chemistry, Medicinal

Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics

Sharba Tasneem, Mohammad Mumtaz Alam, Mohammad Amir, Mymoona Akhter, Suhel Parvez, Garima Verma, Lalit Mohan Nainwal, Ashif Equbal, Tarique Anwer, Mohammad Shaquiquzzaman

Summary: The regulation of genes through post-translational modification of proteins, known as "epigenetic" regulation, has been extensively studied for disease therapies, especially cancer chemotherapeutics. Histone deacetylases (HDACs) are important targets in epigenetic regulation and play a crucial role in balancing acetylation/deacetylation of lysine amino acids on histone/nonhistone proteins. HDAC inhibitors (HDACIs) are biologically active compounds that have become essential for cancer treatment due to their ability to induce cell cycle arrest, differentiation, and apoptosis in tumor cells.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2022)

Review Cell Biology

Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition

Barkha Sharma, Garvit Satija, Anish Madan, Mansi Garg, M. Mumtaz Alam, M. Shaquiquzzaman, Suruchi Khanna, Prachi Tiwari, Suhel Parvez, Ashif Iqubal, Syed Ehtaishamul Haque, Mohammad Ahmed Khan

Summary: Alzheimer's disease is a complex neurodegenerative disorder with unclear etiology and pathology. Recent research has highlighted the involvement of inflammasomes, particularly the NLRP3 inflammasome, in the disease. NLRP3 is a critical receptor involved in immune responses and has been found to play a significant role in various immunological and neurological disorders. Inhibiting the activity of the NLRP3 inflammasome has been suggested as a promising approach for preventing and treating Alzheimer's disease.

INFLAMMATION (2023)

Article Chemistry, Medicinal

Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones

Azizah M. Malebari, Gabriela Duffy Morales, Brendan Twamley, Darren Fayne, Mohemmed Faraz Khan, Eavan C. McLoughlin, Niamh M. O'Boyle, Daniela M. Zisterer, Mary J. Meegan

Summary: This study describes the synthesis, characterization, and mechanism of action of a series of 3-fluoro and 3,3-difluoro substituted beta-lactams as analogues of the tubulin-targeting agent CA-4. These compounds showed potent activity in breast cancer cells and low toxicity in non-cancerous cells. Mechanistic studies demonstrated that these compounds inhibit tubulin polymerization and induce apoptosis, making them potential candidates for the development of novel cancer therapeutics.

PHARMACEUTICALS (2022)

Article Chemistry, Medicinal

Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agents

Shweta Sharma, Mohd. Hafizur Rehman Ansari, Kalicharan Sharma, Rajesh K. Singh, Shakir Ali, Mohd. Mumtaz Alam, Mohd. Shaqiquzamman Zaman, Prawez Alam, Mymoona Akhter

Summary: In this study, a series of analogues were synthesized and evaluated, and KB-23, KB-22, and KB-06 showed promising antihyperglycemic potential in both in vitro and in vivo studies, making them potential starting points for the development of antidiabetic agents.

FUTURE MEDICINAL CHEMISTRY (2023)

Article Chemistry, Inorganic & Nuclear

Anticancer heterocyclic hybrids: design, synthesis, molecular docking and evaluation of new thiazolidinone-pyrazoles

Neelima Shrivastava, Shah Alam Khan, Mohammad Mumtaz Alam, Mymoona Akhtar, Apeksha Srivastava, Asif Husain

Summary: To discover potential anticancer agents, hybrid compounds were synthesized by combining thiazolidinone and pyrazole scaffolds. Among these compounds, 2-(1,3-diphenyl-1H-pyrazol-4-yl)-3-phenyl thiazolidin-4-one (4a) showed the most potency with a docking score of -9.307 and a binding score of -66.46, as well as good ADME parameters. In vitro studies indicated that compound 4a exhibited the highest inhibition against lung cancer (NCI-H23) cell lines with a moderate inhibition rate of 31.01%. Molecular docking analysis revealed that these hybrid compounds bind well to the active site of peroxisome proliferator-activated receptors-gamma (PPAR-gamma). Doxorubicin was used as a positive control. It can be concluded that compound 4a, with a pyrazole-thiazolidinone ring system, has the potential to be developed as an anticancer agent.

ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES (2023)

Article Biochemistry & Molecular Biology

Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent

Shaista Amin, Khursheed A. Sheikh, Ashif Iqubal, Mohammad Ahmed Khan, M. Shaquiquzzaman, Sharba Tasneem, Suruchi Khanna, A. K. Najmi, Mymoona Akhter, Anzarul Haque, Tarique Anwer, M. Mumtaz Alam

Summary: Despite advancements in Diabetes mellitus management, designing and synthesizing drug molecules that effectively improve hyperglycemia and associated complications in diabetic patients remains challenging. In this study, pyrimidine-thiazolidinedione derivatives were synthesized, characterized, and evaluated for their anti-diabetic properties. The synthesized compounds were analyzed using various techniques, including NMR, FTIR, and Mass Spectrometry. In-silico ADME studies confirmed the compounds met Lipinski's rule of five. In-vivo evaluation in diabetic rats showed that compounds 6e and 6m significantly reduced blood glucose levels without causing weight gain. Biochemical and histopathological analyses further supported the anti-diabetic effects of these compounds. Based on these findings, pyrimidine-based thiazolidinedione derivatives could be considered as novel anti-diabetic agents with minimal side effects.

BIOORGANIC CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Effectiveness of estrogen and its derivatives over dexamethasone in the treatment of COVID-19

Darakhshan Parveen, Anwesha Das, Shaista Amin, M. Mumtaz Alam, Mymoona Akhter, Mohammad Ahmed Khan, Ruhi Ali, Tarique Anwer, Khursheed A. Sheikh, Faizul Azam, M. Shaquiquzzaman

Summary: COVID-19 is caused by SARS-CoV-2 virus and dexamethasone is widely used for its treatment. Estrogen and Estetrol, which possess immunoenhancer properties, were tested as potential treatments for COVID-19. Molecular docking and simulations showed that these test ligands have drug-like properties and better binding potential than Dexamethasone. MD Simulation revealed that the interactions of these ligands are similar to drugs with in vitro anticovid activity. Further in vitro and in vivo studies are needed to confirm their potential against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Chemistry, Multidisciplinary

Melatonin Mitigates Rotenone-Induced Oxidative Stress and Mitochondrial Dysfunction in the Drosophila melanogaster Model of Parkinson's Disease-like Symptoms

Md. Zeeshan Rasheed, Rehana Khatoon, Faizia Talat, Mohammad Mumtaz Alam, Heena Tabassum, Suhel Parvez

Summary: This study investigated the therapeutic effect of melatonin against rotenone-induced toxicity in the Drosophila model of PD. It found that melatonin reduced mortality and climbing ability of Drosophila and alleviated oxidative stress and mitochondrial dysfunctions.

ACS OMEGA (2023)

Article Chemistry, Medicinal

Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancer

Sharba Tasneem, M. Mumtaz Alam, Suhel Parvez, Farah Pinky, Farah Khan, Manika Garg, Mohd. Amir, Mymoona Akhter, Shaista Amin, Mohammad Ahmed Khan, Mohammad Shaquiquzzaman

Summary: In this study, the authors synthesized and evaluated 27 novel coumarin-based amide derivatives for their HDAC1 inhibitory activity. They found that two of the compounds showed better activity than existing drugs. These coumarin derivatives exhibited promising potential as anticancer agents and should be further developed.

FUTURE MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

DataPype: A Fully Automated Unified Software Platform for Computer-Aided Drug Design

Mohemmed Faraz Khan, Shubhangi Kandwal, Darren Fayne

Summary: Computer-aided drug design (CADD) has revolutionized the traditional physical testing methods in drug discovery. However, CADD still faces limitations and challenges. A software platform called DataPype has been developed to streamline data processing and integrate various CADD tools, enhancing the drug discovery process.

ACS OMEGA (2023)

Article Medicine, General & Internal

Curcumin Nanoemulsion: Unveiling Cardioprotective Effects via ACE Inhibition and Antioxidant Properties in Hypertensive Rats

Mohd Ishaq, Mohemmed Faraz Khan, Garima Verma, Akshoo Rathi, Mohammad Adil, Mohammad Faizan, Abul Kalam Najmi, Mohd Akhtar, Omkulthom Al Kamaly, Samar Zuhair Alshawwa, Abdelaaty A. Shahat, Abdulsalam Alhalmi

Summary: This study demonstrates the significant cardio-protective effects of curcumin nanoemulsion through the inhibition of ACE activity and antioxidant properties.

MEDICINA-LITHUANIA (2023)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)